Stay updated on Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial
Sign up to get notified when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.

Latest updates to the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a newer page build. The visible content remains unchanged.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor maintenance update. This does not affect the study details or how users interact with the page.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page shows Revision: v3.6.3, replacing v3.6.2. This reflects a small platform update rather than a substantive content change.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now shows a new site revision, v3.6.2, replacing the previous v3.6.0, indicating a minor platform update. This appears in the site metadata/footer and does not modify the study information displayed.SummaryDifference0.0%

- Check62 days agoChange DetectedEnrollment status updated to indicate recruitment has ended. The page adds new help sections and slightly updates header text and version labeling.SummaryDifference0.2%

- Check69 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This change reflects an updated record version rather than changes to study content.SummaryDifference0.0%

Stay in the know with updates to Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.